Skip to main content

Peer Review reports

From: Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

Original Submission
25 Oct 2019 Submitted Original manuscript
20 Nov 2019 Reviewed Reviewer Report - Sven Hoffner
25 Nov 2019 Reviewed Reviewer Report - Judith Bruchfeld
2 Dec 2019 Reviewed Reviewer Report - Sushil Pandey
15 Dec 2019 Author responded Author comments - Hui Xia
Resubmission - Version 2
15 Dec 2019 Submitted Manuscript version 2
24 Dec 2019 Author responded Author comments - Hui Xia
Resubmission - Version 3
24 Dec 2019 Submitted Manuscript version 3
30 Dec 2019 Author responded Author comments - Hui Xia
Resubmission - Version 4
30 Dec 2019 Submitted Manuscript version 4
Publishing
31 Dec 2019 Editorially accepted
7 Jan 2020 Article published 10.1186/s12879-020-4758-9

You can find further information about peer review here.

Back to article page